Literature DB >> 5157725

Effects of isoprenaline and phenylephrine on energy-rich phosphate compounds and glucose-6-phosphate in smooth and cardiac muscle.

A H Weston.   

Abstract

1. Tension changes produced by phenylephrine and isoprenaline have been examined in four tissues-the guinea-pig taenia coli, the longitudinal muscle strip of rabbit duodenum, the abdominal aorta of the rabbit and the rat heart.2. Changes in the amounts of adenosine triphosphate (ATP), creatine phosphate (CP) and glucose-6-phosphate (G-6-P) associated with the addition of phenylephrine and isoprenaline have been measured in the four tissues using enzymatic fluorimetric analysis.3. An alpha-adrenoceptor-mediated increase in tension (phenylephrine; rabbit aorta) was associated with no change in the amounts of ATP, CP or G-6-P.4. An alpha-adrenoceptor-mediated decrease in tension (phenylephrine; guineapig taenia coli and rabbit duodenum) was associated with no change in the amounts of ATP, CP or G-6-P.5. A beta-adrenoceptor-mediated increase in force of contraction (phenylephrine and isoprenaline; rat heart) was associated with a reduction in the amounts of ATP and CP and an increase in the amount of G-6-P.6. A beta-adrenoceptor-mediated decrease in tension (isoprenaline; guinea-pig taenia coli and rabbit duodenum) was associated with an increase in the amounts of ATP and CP and no change in the amount of G-6-P.7. beta-Adrenoceptor-mediated metabolic changes were antagonized by propranolol.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5157725      PMCID: PMC1665781          DOI: 10.1111/j.1476-5381.1971.tb07189.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

3.  The isolated perfused heart preparation: two suggested improvements.

Authors:  P R Beckett
Journal:  J Pharm Pharmacol       Date:  1970-11       Impact factor: 3.765

4.  Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents.

Authors:  W C Govier
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

5.  Metabolic actions associated with stimulation of alpha- and beta-receptors for adrenaline in smooth muscle.

Authors:  R G Andersson; E Mohme-Lundholm
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

6.  Beta-receptor activity in aorta; variations with age and species.

Authors:  J H Fleisch; H M Maling; B B Brodie
Journal:  Circ Res       Date:  1970-02       Impact factor: 17.367

7.  Changes in the amounts of high-energy phosphate compounds associated with the actions of phenylephrine and isoprenaline on smooth and cardiac muscle.

Authors:  A H Weston
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

8.  The effect of adrenaline on the adenosine otriphosphate and creatine phosphate content of intestinal smooth muscle.

Authors:  E Bueding; E Bülbring; G Gercken; J T Hawkins; H Kuriyama
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

9.  Kinetic studies of epinephrine effects in the perfused rat heart.

Authors:  J R Williamson
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  15 in total

1.  Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents.

Authors:  F J Imms; R L Neame; D A Powis
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

Review 2.  [Alpha-adrenoceptors in the myocardium: incidence and functional significance].

Authors:  A Mügge
Journal:  Klin Wochenschr       Date:  1985-11-04

3.  The positive inotropic effect of phenylephrine in the presence of propranolol. Increase in time to peak force and in relaxation time without increase in c-AMP.

Authors:  R Brückner; I Hackbarth; T Meinertz; B Schmelzle; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

4.  Stimulation by phenylephrine of adrenergic alpha- and beta-receptors in the isolated perfused rabbit heart.

Authors:  J Wagner; M Endoh; D Reinhardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Influence of the metabolic state on the action of phenylephrine on rabbit ileum, guinea-pig vas deferens and atrium.

Authors:  J Wagner; D Reinhardt; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  The effects of isoprenaline and phenylephrine on oxygen consumption in isolated smooth muscle.

Authors:  A H Weston
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

7.  alpha 1-adrenoceptor activation can increase heart rate directly or decrease it indirectly through parasympathetic activation.

Authors:  N A Flavahan; J C McGrath
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

8.  alpha 1-adrenoceptors can mediate chronotropic responses in the rat heart.

Authors:  N A Flavahan; J C McGrath
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

9.  Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by alpha- and beta-adrenoceptors.

Authors:  H J Schümann; M Endo; J Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

10.  The accumulation of adenosine in rabbit intestinal muscle.

Authors:  M E Hulme; A H Weston
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.